V
Veracity Clinical Research | Brisbane, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ASN-002
BCX17725
TAK-279
BMS-986322
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...
Active, not recruiting
Plaque Psoriasis
Drug: TAK-279
This is a first-in-human, Phase 1/1b, 4-part study that includes the evaluation of safety, tolerability, pharmacokinetics (PK), and immunogenicity of...
Enrolling
Netherton Syndrome
Drug: Placebo
Drug: BCX17725
Trial sponsors
A
M
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems